Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer
Interventions: DRUG: Placebo|DRUG: Atezolizumab
Sponsor: NSABP Foundation Inc
Collaborators: Genentech, Inc.|Hoffmann-La Roche